A 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to ...
18h
AZoSensors on MSNAI-Powered Wearable Device Shows Promise in Reducing Nighttime Scratching for Atopic Dermatitis PatientsThe AI-driven wearable sensor demonstrates high accuracy in reducing nighttime scratching for atopic dermatitis, improving ...
Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the North American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results